Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12738775rdf:typepubmed:Citationlld:pubmed
pubmed-article:12738775lifeskim:mentionsumls-concept:C0699040lld:lifeskim
pubmed-article:12738775lifeskim:mentionsumls-concept:C0597357lld:lifeskim
pubmed-article:12738775lifeskim:mentionsumls-concept:C0184512lld:lifeskim
pubmed-article:12738775lifeskim:mentionsumls-concept:C0017262lld:lifeskim
pubmed-article:12738775lifeskim:mentionsumls-concept:C1418835lld:lifeskim
pubmed-article:12738775lifeskim:mentionsumls-concept:C2003941lld:lifeskim
pubmed-article:12738775lifeskim:mentionsumls-concept:C2911684lld:lifeskim
pubmed-article:12738775lifeskim:mentionsumls-concept:C0185117lld:lifeskim
pubmed-article:12738775pubmed:issue34lld:pubmed
pubmed-article:12738775pubmed:dateCreated2003-8-18lld:pubmed
pubmed-article:12738775pubmed:abstractTextThe third intracellular (3i) loops of the alpha 2A- and alpha 2B-adrenergic receptor (AR) subtypes are critical for retention of these receptors at the basolateral surface of polarized Madin-Darby canine kidney (MDCKII) cells at steady state. The third intracellular loops of the alpha 2A, alpha 2B, and alpha 2C-AR subtypes interact with spinophilin, a multidomain protein that, like the three alpha 2-AR subtypes, is enriched at the basolateral surface of MDCKII cells. The present studies provide evidence that alpha 2-AR interaction with spinophilin contributes to cell surface stabilization of the receptor. We exploited the unique targeting profile of the alpha 2B-AR subtype in MDCKII cells: random delivery to apical and basolateral surfaces with rapid (t(1/2) < or = 60 min) apical versus slower (t(1/2) = 10-12 h) basolateral turnover. Apical delivery of a spinophilin subdomain containing the alpha 2-AR-interacting region (Sp151-483) by fusion with apically targeted p75NTR extended the half-life of alpha 2B-AR at the apical surface to approximately 3.6 h and eliminated the rapid phase (0-60 min) of alpha 2B-AR turnover on that surface. Furthermore, we examined alpha 2B-AR turnover at the surface of mouse embryo fibroblasts derived from wild type (Sp+/+) or spinophilin knock-out (Sp-/-) mice. Two independent experimental approaches demonstrated that agonist-evoked internalization of HA-alpha 2B-AR was accelerated in mouse embryo fibroblasts derived from Sp-/- mice. These findings are consistent with the interpretation that endogenous spinophilin contributes to the stabilization of alpha 2B-AR and presumably all three alpha2-AR subtypes at the surface of target cells and may act as a scaffold that could link alpha 2-ARs to proteins interacting with spinophilin via other domains.lld:pubmed
pubmed-article:12738775pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12738775pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12738775pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12738775pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12738775pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12738775pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12738775pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12738775pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12738775pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12738775pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12738775pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12738775pubmed:languageenglld:pubmed
pubmed-article:12738775pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12738775pubmed:citationSubsetIMlld:pubmed
pubmed-article:12738775pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12738775pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12738775pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12738775pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12738775pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12738775pubmed:statusMEDLINElld:pubmed
pubmed-article:12738775pubmed:monthAuglld:pubmed
pubmed-article:12738775pubmed:issn0021-9258lld:pubmed
pubmed-article:12738775pubmed:authorpubmed-author:LimbirdLee...lld:pubmed
pubmed-article:12738775pubmed:authorpubmed-author:WangQinQlld:pubmed
pubmed-article:12738775pubmed:authorpubmed-author:GreengardPaul...lld:pubmed
pubmed-article:12738775pubmed:authorpubmed-author:BradyAshley...lld:pubmed
pubmed-article:12738775pubmed:authorpubmed-author:AllenPatrick...lld:pubmed
pubmed-article:12738775pubmed:authorpubmed-author:ColbranRoger...lld:pubmed
pubmed-article:12738775pubmed:issnTypePrintlld:pubmed
pubmed-article:12738775pubmed:day22lld:pubmed
pubmed-article:12738775pubmed:volume278lld:pubmed
pubmed-article:12738775pubmed:ownerNLMlld:pubmed
pubmed-article:12738775pubmed:authorsCompleteYlld:pubmed
pubmed-article:12738775pubmed:pagination32405-12lld:pubmed
pubmed-article:12738775pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:12738775pubmed:meshHeadingpubmed-meshheading:12738775...lld:pubmed
pubmed-article:12738775pubmed:meshHeadingpubmed-meshheading:12738775...lld:pubmed
pubmed-article:12738775pubmed:meshHeadingpubmed-meshheading:12738775...lld:pubmed
pubmed-article:12738775pubmed:meshHeadingpubmed-meshheading:12738775...lld:pubmed
pubmed-article:12738775pubmed:meshHeadingpubmed-meshheading:12738775...lld:pubmed
pubmed-article:12738775pubmed:meshHeadingpubmed-meshheading:12738775...lld:pubmed
pubmed-article:12738775pubmed:meshHeadingpubmed-meshheading:12738775...lld:pubmed
pubmed-article:12738775pubmed:meshHeadingpubmed-meshheading:12738775...lld:pubmed
pubmed-article:12738775pubmed:meshHeadingpubmed-meshheading:12738775...lld:pubmed
pubmed-article:12738775pubmed:meshHeadingpubmed-meshheading:12738775...lld:pubmed
pubmed-article:12738775pubmed:meshHeadingpubmed-meshheading:12738775...lld:pubmed
pubmed-article:12738775pubmed:meshHeadingpubmed-meshheading:12738775...lld:pubmed
pubmed-article:12738775pubmed:meshHeadingpubmed-meshheading:12738775...lld:pubmed
pubmed-article:12738775pubmed:year2003lld:pubmed
pubmed-article:12738775pubmed:articleTitleSpinophilin stabilizes cell surface expression of alpha 2B-adrenergic receptors.lld:pubmed
pubmed-article:12738775pubmed:affiliationDepartment of Pharmacology, Center for Molecular Neuroscience, Vanderbilt University Medical Center, Nashville, Tennessee 37232-6600, USA.lld:pubmed
pubmed-article:12738775pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:12738775pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:12738775pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:11552entrezgene:pubmedpubmed-article:12738775lld:entrezgene
entrez-gene:217124entrezgene:pubmedpubmed-article:12738775lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:12738775lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12738775lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12738775lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12738775lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12738775lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12738775lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12738775lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12738775lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12738775lld:pubmed